Core Viewpoint - The recent transfer of shares in Great Health International (02211) indicates a significant shift in shareholder structure, while the company's financial performance shows a notable decline in revenue and profitability due to external factors [1] Group 1: Shareholder Activity - On January 29, Great Health International's shares were transferred from Yue Shang International Securities to HSBC Hong Kong, with a market value of HKD 85.515 million, representing 14.68% of the total shares [1] Group 2: Financial Performance - For the fiscal year ending June 30, 2025, Great Health International reported revenues of approximately HKD 711.5 million, a decrease of 34.7% year-on-year [1] - The company's gross profit was approximately HKD 113.4 million, reflecting a year-on-year decline of 37% [1] - The company reported a loss attributable to shareholders of HKD 26.06 million, marking a shift from profit to loss compared to the previous year, with a loss per share of HKD 0.3246 [1] Group 3: Factors Influencing Performance - The decline in revenue is primarily attributed to the impact of new healthcare insurance policies in China and a decrease in the number of active customers within the national distribution network [1]
大健康国际股东将股票由粤商国际证券转入香港上海汇丰银行 转仓市值8551.5万港元